Related Experiment Video
Updated: Sep 13, 2026
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
Liza Konnikova1, Maciej Kotecki, Mathew M Kruger
1Department of Physiology, Tufts University School of Medicine, 136 Harrison Ave, Boston, Massachusetts 02111, USA. liza.konnikova@tufts.edu
Background:
Astrocytomas are the most common type of primary central nervous system tumors. They are frequently associated with genetic mutations that deregulate cell cycle and render these tumors resistant to apoptosis. STAT3, signal transducer and activator of transcription 3, participates in several human cancers by inducing cell proliferation and inhibiting apoptosis and is frequently activated in astrocytomas.
Methods:
RNA interference was used to knockdown STAT3 expression in human astrocytes and astrocytoma cell lines. The effect of STAT3 knockdown on apoptosis, cell proliferation, and gene expression was then assessed by standard methods.
Results:
We have found that STAT3 is constitutively activated in several human astrocytoma cell lines. Knockdown of STAT3 expression by siRNA induces morphologic and biochemical changes consistent with apoptosis in several astrocytoma cell lines, but not in primary human astrocytes. Moreover, STAT3 is required for the expression of the antiapoptotic genes survivin and Bcl-xL in the A172 glioblastoma cell line.
Conclusion:
These results show that STAT3 is required for the survival of some astrocytomas. These studies suggest STAT3 siRNA could be a useful therapeutic agent for the treatment of astrocytomas.
Insights
Signal transducer and activator of transcription 3 (STAT3) is crucial for astrocytoma survival. Inhibiting STAT3 with siRNA triggers apoptosis in these brain tumors, suggesting a potential therapeutic strategy.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Genetics
Background:
- Astrocytomas represent the most prevalent primary central nervous system tumors.
- Genetic mutations in astrocytomas often disrupt cell cycle regulation and promote resistance to programmed cell death (apoptosis).
- Signal transducer and activator of transcription 3 (STAT3) is frequently activated in astrocytomas, contributing to tumor cell proliferation and apoptosis inhibition.
Purpose of the Study:
- To investigate the role of STAT3 in astrocytoma cell survival and proliferation.
- To evaluate the therapeutic potential of targeting STAT3 in astrocytoma treatment.
Main Methods:
- RNA interference (siRNA) was employed to reduce STAT3 expression in human astrocytes and astrocytoma cell lines.
- Standard assays were utilized to assess the impact of STAT3 knockdown on apoptosis, cell proliferation, and gene expression.
Main Results:
- Constitutive activation of STAT3 was observed in multiple human astrocytoma cell lines.
- STAT3 knockdown induced apoptosis in astrocytoma cells but not in primary astrocytes.
- STAT3 was essential for the expression of anti-apoptotic genes, including survivin and Bcl-xL, in the A172 glioblastoma cell line.
Conclusions:
- STAT3 is indispensable for the survival of certain astrocytomas.
- STAT3 siRNA demonstrates promise as a potential therapeutic agent for astrocytoma treatment.
